NATHBIOGENOther Agricultural Products
Nath Bio Genes India Limited — Cash Flow Statement
₹129.02
-6.22%
Nath Bio Genes India Limited Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | 9.66 Cr | 47.82 Cr | 35.82 Cr | 15.93 Cr | — |
| Capital Expenditure | -7.92 Cr | -26.78 Cr | -2.55 Cr | -1.12 Cr | — |
| End Cash Position | 88.90 Cr | 77.41 Cr | 38.00 Cr | 4.18 Cr | — |
| Beginning Cash Position | 77.41 Cr | 38.00 Cr | 4.18 Cr | 29.22 Cr | — |
| Changes In Cash | 11.49 Cr | 39.41 Cr | 33.81 Cr | -25.04 Cr | — |
| Financing Cash Flow | -2.13 Cr | -7.78 Cr | -1.67 Cr | -22.23 Cr | — |
| Interest Paid Cff | -10.48 Cr | -9.11 Cr | -10.12 Cr | -10.61 Cr | — |
| Cash Dividends Paid | -3.80 Cr | -3.80 Cr | -3.80 Cr | -3.80 Cr | — |
| Net Issuance Payments Of Debt | 12.15 Cr | 5.13 Cr | 12.25 Cr | -7.82 Cr | — |
| Net Short Term Debt Issuance | 4.04 Cr | 2.71 Cr | 12.52 Cr | -7.83 Cr | — |
| Net Long Term Debt Issuance | 8.11 Cr | 2.42 Cr | -0.26 Cr | 0.01 Cr | — |
| Investing Cash Flow | -3.96 Cr | -27.40 Cr | -2.88 Cr | -19.85 Cr | — |
| Net Other Investing Changes | 1000.00 | 1000.00 | -0.40 Cr | -19.90 Cr | — |
| Interest Received Cfi | 3.59 Cr | 0.32 Cr | 0.02 Cr | 1.09 Cr | — |
| Net Investment Purchase And Sale | 0.26 Cr | -1.00 Cr | -2000.00 | -3000.00 | — |
| Sale Of Investment | 0.26 Cr | — | — | — | — |
| Net PPE Purchase And Sale | -7.82 Cr | -26.73 Cr | -2.43 Cr | -1.03 Cr | — |
| Sale Of PPE | 0.11 Cr | 0.05 Cr | 0.05 Cr | 0.07 Cr | — |
| Purchase Of PPE | -7.92 Cr | -26.78 Cr | -2.48 Cr | -1.10 Cr | — |
| Operating Cash Flow | 17.58 Cr | 74.59 Cr | 38.37 Cr | 17.05 Cr | — |
| Taxes Refund Paid | -1.08 Cr | -0.34 Cr | -0.92 Cr | -2.88 Cr | — |
| Change In Working Capital | -34.95 Cr | 23.09 Cr | -9.81 Cr | -18.93 Cr | — |
| Change In Other Current Liabilities | 63.22 Cr | 28.82 Cr | 25.79 Cr | 12.55 Cr | — |
| Change In Other Current Assets | -2.47 Cr | -1.13 Cr | -0.39 Cr | -0.22 Cr | — |
| Change In Payable | 36.19 Cr | 15.56 Cr | -15.05 Cr | 19.99 Cr | — |
| Change In Inventory | -107.71 Cr | -22.46 Cr | 12.50 Cr | 5.96 Cr | — |
| Change In Receivables | -24.18 Cr | 2.30 Cr | -32.66 Cr | -57.21 Cr | — |
| Other Non Cash Items | 6.56 Cr | 9.72 Cr | 10.12 Cr | 9.35 Cr | — |
| Provisionand Write Offof Assets | -0.54 Cr | -3.45 Cr | 0.00 | 88.78 Cr | — |
| Depreciation And Amortization | 3.82 Cr | 3.26 Cr | 3.01 Cr | 3.08 Cr | — |
| Depreciation | 3.82 Cr | 3.26 Cr | 1.37 Cr | 1.48 Cr | — |
| Pension And Employee Benefit Expense | 0.51 Cr | 0.51 Cr | -0.32 Cr | 0.63 Cr | — |
| Gain Loss On Sale Of PPE | 1.04 Cr | -10000.00 | 12000.00 | -36000.00 | — |
| Net Income From Continuing Operations | 40.58 Cr | 41.56 Cr | 36.16 Cr | -63.43 Cr | — |
| Other Cash Adjustment Outside Changein Cash | — | 1000.00 | -1000.00 | -14000.00 | -1000.00 |
| Net Other Financing Charges | — | -1000.00 | — | 0.02 Cr | -1.00 |
| Purchase Of Investment | — | -1.00 Cr | -2000.00 | -3000.00 | -0.05 Cr |
| Net Intangibles Purchase And Sale | — | 0.00 | -0.07 Cr | -0.01 Cr | -0.05 Cr |
| Purchase Of Intangibles | — | 0.00 | -0.07 Cr | -0.01 Cr | -0.05 Cr |
| Amortization Cash Flow | — | 1.61 Cr | 1.64 Cr | 1.61 Cr | — |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Nath Bio Genes India Limited
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.